Related Experiment Videos
Limited macular translocation for neovascular maculopathy
J A Haller1, C D Hartranft, G Y Fujii
1Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, MD 21287, USA. jhaller@jhmi.edu
Seminars in Ophthalmology
|April 20, 2001
Summary
Limited macular translocation surgery moves the fovea to treat subfoveal choroidal neovascularization. This promising approach helps selected patients retain useful central vision, with about 40% achieving driving ability.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Neovascular Maculopathy
Background:
- Subfoveal choroidal neovascularization (CNV) causes irreversible vision loss due to photoreceptor damage.
- Current treatments fail to adequately address subretinal hemorrhage and scarring in CNV.
- Macular translocation offers a surgical alternative for challenging CNV cases.
Purpose of the Study:
- To describe the technique of limited macular translocation (LMT).
- To review the early outcomes and complications of LMT for subfoveal CNV.
- To evaluate LMT as a potential treatment for preserving central vision.
Main Methods:
- Surgical translocation of the fovea to an adjacent healthy retinal area.
- Post-operative focal laser photocoagulation for newly juxtafoveal/extrafoveal CNV.
- Assessment of visual acuity, complications, and functional vision (reading, driving).
Main Results:
- Approximately 40% of patients achieved visual acuity >20/100 at 6 months, enabling reading and driving.
- Complications such as retinal detachment, hemorrhage, and macular folds were observed.
- Surgical experience led to a decrease in complication rates.
Conclusions:
- Limited macular translocation is a viable surgical option for selected patients with subfoveal CNV.
- The procedure offers a chance for vision restoration and improved quality of life.
- Ongoing evaluation is necessary to further refine the technique and assess long-term efficacy.